⌘K

Login Start Free

Home/Filings/4/0001062993-18-003109

4//SEC Filing

Wegman Thomas 4

Accession 0001062993-18-003109

CIK 0000875622other

View on SEC.gov Company Profile

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 9:38 PM ET

Size

6.3 KB

Accession

0001062993-18-003109

Insider Transaction Report

Form 4

Period: 2018-08-02

BIOSPECIFICS TECHNOLOGIES CORPBSTC

DirectorPresident10% Owner

Transactions

Conversion
Common Stock, $0.001 par value
2018-08-02$21.00/sh+50,000$1,050,000→ 336,327 total
Conversion
Stock Option (Right to Buy)
2018-08-02−50,000→ 0 total
Exercise: $21.00From: 2018-08-02Exp: 2018-08-02→ Common Stock, $.001 par value (50,000 underlying)

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1

filerCIK 0001355189

Filing Metadata

Form type: 4
Filed: Aug 1, 8:00 PM ET
Accepted: Aug 2, 9:38 PM ET
Size: 6.3 KB

View on SEC.gov